Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: do different measures identify the same patients?
暂无分享,去创建一个
F. Blyth | W. Hall | R. Mattick | R. Bruno | S. Nielsen | B. Larance | L. Degenhardt | G. Campbell | Milton L Cohen | N. Lintzeris | M. Farrell
[1] R. Mattick,et al. Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: The Opioid-Related Behaviours In Treatment (ORBIT) scale. , 2016, Drug and alcohol dependence.
[2] J. Boscarino,et al. Opioid-use disorder among patients on long-term opioid therapy: impact of final DSM-5 diagnostic criteria on prevalence and correlates , 2015, Substance abuse and rehabilitation.
[3] R. Dworkin,et al. Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic Review. , 2015, The journal of pain : official journal of the American Pain Society.
[4] J. Ballantyne. Assessing the prevalence of opioid misuse, abuse, and addiction in chronic pain. , 2015, Pain.
[5] W. Hall,et al. Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort study. , 2015, The lancet. Psychiatry.
[6] K. Vowles,et al. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis , 2015, Pain.
[7] R. Chou,et al. The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop , 2015, Annals of Internal Medicine.
[8] G. Arbanas. Diagnostic and Statistical Manual of Mental Disorders (DSM-5) , 2015 .
[9] S. Nielsen,et al. Comparing opioids: A guide to estimating oral morphine equivalents (OME) in research , 2014 .
[10] W. Hall,et al. Cohort protocol paper: The Pain and Opioids In Treatment (POINT) study , 2014, BMC Pharmacology and Toxicology.
[11] R. Dworkin,et al. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations , 2013, PAIN®.
[12] B. Löwe,et al. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. , 2010, General hospital psychiatry.
[13] C. Banta-Green,et al. Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain , 2010, PAIN®.
[14] David R. Williams,et al. Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. , 2009, Archives of general psychiatry.
[15] M. Wiederman,et al. The Prevalence of Childhood Trauma Among Those Seeking Buprenorphine Treatment , 2009, Journal of addictive diseases.
[16] M. Sullivan,et al. (378) Suicidal ideation, plans and attempts among individuals with chronic pain conditions: Data from the National Co-morbidity Survey Replication , 2008 .
[17] Ronald C. Kessler,et al. The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders. , 2008 .
[18] Dan J Stein,et al. Mental disorders among persons with chronic back or neck pain: Results from the world mental health surveys , 2007, PAIN.
[19] Bridget A. Martell,et al. Systematic Review: Opioid Treatment for Chronic Back Pain: Prevalence, Efficacy, and Association with Addiction , 2007, Annals of Internal Medicine.
[20] Fausto Mazzi,et al. Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health Surveys , 2006, International journal of methods in psychiatric research.
[21] B. Löwe,et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. , 2006, Archives of internal medicine.
[22] A. Viera,et al. Understanding interobserver agreement: the kappa statistic. , 2005, Family medicine.
[23] J. Farrar,et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations , 2003, Pain.
[24] R. Dworkin,et al. Suicidal ideation, plans, and attempts in chronic pain patients: factors associated with increased risk , 2004, Pain.
[25] T. B. Üstün,et al. The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) , 2004, International journal of methods in psychiatric research.
[26] J. Sheikh,et al. The primary care PTSD screen (PC-PTSD): development and operating characteristics , 2004 .
[27] J. Farrar,et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations , 2003, Pain.
[28] Definitions related to the use of opioids for the treatment of pain. , 2001, WMJ : official publication of the State Medical Society of Wisconsin.
[29] R. Spitzer,et al. The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.
[30] Andrew Mackinnon,et al. A spreadsheet for the calculation of comprehensive statistics for the assessment of diagnostic tests and inter-rater agreement , 2000, Comput. Biol. Medicine.
[31] S. Darke,et al. Self-report among injecting drug users: a review. , 1998, Drug and alcohol dependence.
[32] N Sartorius,et al. WHO Study on the reliability and validity of the alcohol and drug use disorder instruments: overview of methods and results. , 1997, Drug and alcohol dependence.
[33] W. Thomas Edwards,et al. Development and initial validation of a scale to measure self-efficacy beliefs in patients with chronic pain , 1995, Pain.
[34] P. Richardson,et al. Attrition from a pain management programme. , 1995, The British journal of clinical psychology.